Can a patient with diabetes mellitus (DM) be considered non-diabetic if they achieve a hemoglobin A1c (HbA1c) below 6.5% through lifestyle modifications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

A patient with diabetes mellitus (DM) who achieves a hemoglobin A1c (HbA1c) below 6.5% through lifestyle modifications is still considered to have diabetes. The American College of Physicians guidance statement 1 emphasizes that diabetes is a chronic condition that requires ongoing management and monitoring, even if blood glucose levels are well-controlled. The statement highlights the importance of personalized goals for glycemic control, taking into account the benefits and harms of pharmacotherapy, patient preferences, and individual characteristics such as life expectancy and comorbid conditions. Key points to consider include:

  • Diabetes is a chronic condition that can be managed but not cured
  • Achieving an HbA1c below 6.5% through lifestyle modifications does not remove the diagnosis of diabetes
  • Healthcare providers will continue to classify patients as having diabetes in remission or with well-controlled diabetes
  • Regular monitoring remains essential to catch potential complications early
  • The American Diabetes Association recognizes that some patients can achieve "remission" if blood glucose levels remain normal without medication for at least three months, but this doesn't mean the condition is permanently gone 1. Therefore, even if a patient's HbA1c level drops below 6.5% through lifestyle changes, they are still considered to have diabetes and require ongoing medical care and monitoring.

From the Research

Definition of Diabetes Mellitus (DM)

A patient with diabetes mellitus (DM) is typically defined by their blood glucose levels, with a hemoglobin A1c (HbA1c) level of 6.5% or higher being a common diagnostic criterion 2.

Achieving HbA1c Below 6.5% Through Lifestyle Modifications

Some studies suggest that lifestyle interventions, such as diet and exercise, can be effective in reducing HbA1c levels in patients with type 2 diabetes 2, 3. For example, a study found that lifestyle interventions were associated with reductions in the incidence of diabetes and improved intermediate outcomes, such as reduced weight and blood pressure 2.

Implications of Achieving HbA1c Below 6.5%

However, achieving an HbA1c level below 6.5% through lifestyle modifications does not necessarily mean that a patient can be considered non-diabetic. The underlying pathophysiology of the disease is still present, and the patient may still require ongoing management and monitoring to prevent complications 4, 5.

Key Points to Consider

  • A diagnosis of diabetes is based on multiple factors, including blood glucose levels, medical history, and physical examination 4.
  • Lifestyle modifications can be effective in reducing HbA1c levels, but may not necessarily mean that a patient can be considered non-diabetic 2, 3.
  • Ongoing management and monitoring are still necessary to prevent complications, even if HbA1c levels are below 6.5% 4, 5.
  • The use of medications, such as metformin, may still be necessary to achieve and maintain glycemic control 5, 6.

Treatment Options

Treatment options for patients with type 2 diabetes who achieve an HbA1c level below 6.5% through lifestyle modifications may include:

  • Continued lifestyle modifications, such as diet and exercise 2, 3.
  • Medications, such as metformin, to help maintain glycemic control 5, 6.
  • Ongoing monitoring and management to prevent complications 4, 5.

Related Questions

For a 19‑year‑old with type 1 diabetes, weight 86 kg, creatinine 0.74 mg/dL, GFR > 90 mL/min, bicarbonate 17 mmol/L, anion gap 13, currently on metformin 750 mg daily and insulin glargine (Lantus) 15 U at 8 am and 35 U at 8 pm with carbohydrate‑to‑insulin ratios of 1 U per 6 g carbs at breakfast and 1 U per 7 g carbs at lunch/dinner and an insulin‑sensitivity factor of 25 mg/dL per U, and blood glucose values of 184 mg/dL (8 am), 220 mg/dL (noon), 262 mg/dL (5 pm), 237 mg/dL (10 pm), and 97 mg/dL (4 am), what should the morning and evening Lantus doses be and what should the insulin‑sensitivity factor and insulin‑to‑carbohydrate ratios be adjusted to?
What does a basal insulin level of 2.3 (microunits per milliliter) indicate in a 48-year-old man with no known diabetes?
In a 27‑year‑old woman with type 2 diabetes, weight 86.6 kg, creatinine 0.40 mg/dL, GFR > 90 mL/min, currently taking neutral protamine Hagedorn (NPH) insulin 32 U at 8 am, dexamethasone 20 mg daily, with an insulin‑to‑carbohydrate ratio (ICR) of 1 U per 3 g carbohydrate and an insulin sensitivity factor (ISF) of 25 mg/dL per U, and blood glucose values of 207 mg/dL at 9 am, 229 mg/dL after a 90‑g carbohydrate meal, 373 mg/dL at 5 pm, 340 mg/dL at 9 pm, and 286 mg/dL at 2 am, what should the NPH basal insulin dose, ISF, and ICR be adjusted to?
A 28‑week‑gestation pregnant woman weighing 114 kg has a fasting blood glucose of 157 mg/dL while on insulin glargine (Lantus) 40 units daily; how much should the insulin glargine dose be increased?
How should a 19‑year‑old female with a family history of diabetes, normal fasting glucose (88 mg/dL) and HbA1c (5.2 %), but elevated fasting insulin (47.3 µU/mL) be managed?
Is a single dose of Pneumococcal Conjugate Vaccine (PCV) 21 effective?
What is the difference between Acute Disseminated Encephalomyelitis (ADEM) and Guillain-Barré Syndrome (GBS)?
Can intravenous Dimethyl Sulfoxide (DMSO) cause renal impairment?
Can a patient with liver cirrhosis take aspirin (acetylsalicylic acid) 325 milligrams daily?
What is the relationship between Transthyretin (ATTR) Cardiomyopathy and elevated D-Dimer levels?
Can sickle cell crisis cause elevated liver enzymes (transaminitis)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.